Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3201–3250 of 33040
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
each of Kevin Barber, David S. Dury, Dorothy D. Hayes, Nigel Hunton, Michele F. Klein, Eiji Miyanaga, and Ryan Vardeman resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof, effective as of the Effective Time
On March 28, 2025, Lynn L. Elsenhans informed Baker Hughes Company (the “Company”) that she will not stand for re-election at the Company’s upcoming 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”).
On March 26, 2025, David Gibbs, the Company’s Chief Executive Officer, informed the Board of Directors of his intention to retire in 2026.
Simultaneous with the closing of the Transaction, Justin Cochrane, Chief Executive Officer of Clear Channel UK & Europe, has ceased to be an employee of the Company.
the Company and Tarak B. Mehta, the President and Chief Executive Officer of the Company, had mutually agreed that Mr. Mehta would depart from the Company, including resigning as a member of the Company’s Board of Directors (the “Board”), effective immediately.
On March 25, 2025, it was agreed that the employment of Eric Hyllengren, the Chief Financial Officer and Chief Operating Officer of Atara Biotherapeutics, Inc. (the “ Company ”), would end effective March 31, 2025.
On March 31, 2025, Lloyd Segal, President and Chief Executive Officer of Repare Therapeutics Inc. (the “ Company ”), notified the board of directors (the “ Board ”) of the Company of his resignation from his positions as President and Chief Executive Officer and as a member of the Board, effective April 11, 2025
On March 27, 2025, the Board terminated Michael T. Broderick from his positions as President and Chief Executive Officer of the Company effective immediately.
He will succeed Jeffrey J. Lyash, who is retiring from his position with TVA and will continue to serve for up to 30 days to support the transition.
James L. Marvin, the Executive Vice President and Chief Legal Officer of JBT Marel Corporation (the “Company”), announced his intention to retire on May 31, 2025.
announce the retirement of John R. Showers from the Board of Directors of the Company and the Bank, effective March 31, 2025.
On March 25, 2025, Jeetu Patel, a member of the Board of Directors (the “Board”) of Equinix, Inc. (the “Company”) since June 2022, notified the Board that he would not stand for reelection as a director of the Company.
the Company's Chief Financial Officer, Sunit Patel, resigned, and Valarie Sheppard, a member of the Company's Board of Directors (the 'Board'), assumed the role of Interim Chief Financial Officer, effective March 14, 2025.
On February 25, 2025, Mr. Ernest Scheidemann informed First Choice Healthcare Solutions, Inc. (the “Company”) of his resignation as the Interim Chief Financial Officer of the Company, effective as of February 25, 2025.
the Board of Directors removed Mr. Hummel as a Director of the Company
Joseph Hummel resigned as Chief Executive Officer of Twin Hospitality Group Inc.
Clay Mingus resigned as Chief Legal Officer of the Company
On March 31, 2025, Ilustrato Pictures International Inc. (the “Company”) confirms John-Paul Backwell’s resignation as an Officer and Managing Director, effective immediately.
Jennifer Moyer, a member of the Board and Chair of the Nominating and Corporate Governance Committee, notified the Company that she would not stand for re-election to Class II of the Board.
On March 26, 2025, Alex Moinian notified LuxUrban Hotels Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”), effective immediately. Mr. Moinian’s resignation was due to personal reasons and was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices.
On March 25, 2025, Peter S. Norgeot, Jr., Executive Vice President and Chief Operating Officer of Entergy Corporation (the “Company”) and a member of the Board of Directors of Entergy Arkansas, LLC , Entergy Louisiana, LLC , Entergy Mississippi, LLC , Entergy New Orleans, LLC and Entergy Texas, Inc. (collectively, the “Operating Company Registrants”), advised the Company and each of the Operating Company Registrants that he intends to retire from these positions at the close of business on April 30, 2025, as part of a planned leadership transition.
On March 26, 2025, Cynthia Booth notified First Financial Bancorp (the “Company”) of her decision to retire as a director of the Company effective at the end of her current term.
Ms. Olshan will step down as the Company’s Chief Executive Officer and President ("CEO") and as a member of the Board effective as of April 11, 2025
On March 26, 2025, Raja Akram informed Morgan Stanley of his intent to resign from his position as Deputy Chief Financial Officer, Chief Accounting Officer and Controller to pursue another opportunity, subsequent to the fulfillment of the required notice period.
On March 24, 2025, Michelle L. Mellion, MD resigned from her position as Chief Medical Officer of PepGen Inc.
On March 25, 2025, Dr. Gary Romano gave notice of his decision to resign from his position as Chief Medical Officer of Alector, Inc. (the “Company”) in order to pursue other opportunities.
On March 24, 2025, Katharina Otto-Bernstein, a member of the Board of Directors (the “Board”) of Paramount Group, Inc. (the “Company”), notified the Board of her decision to retire from the Board and not to stand for reelection as a director at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
On March 25, 2025, Mr. Mark DiPaolo notified Amarin Corporation plc (the “Company”) that he has made the decision not to stand for re-election at the 2025 Annual Meeting of Shareholders.
On March 27, 2025, and with immediate effect, Dr. Sheldon Retchin, a Class III Director of Aveanna Healthcare Holdings Inc., a Delaware corporation (the "Company"), notified the Company of his resignation from the Company's Board of Directors for personal health reasons.
On February 27, 2025, the Company terminated the employment of Jorge Aldecoa as the Company’s Chief Product Officer, effective immediately.
On March 24, 2025, Grace A. Huebscher notified us of her resignation from the Federal Home Loan Mortgage Corporation (Freddie Mac) Board of Directors, effective as of that date.
On March 24, 2025, Briley Brisendine, the Company’s Executive Vice President, General Counsel and Secretary, notified the Company of his intent to resign from the Company.
Cathy McCarthy would not stand for re-election as a Class III director on the Board of Directors of the Company (the “Board”) upon the completion of her current term, which expires at the Company’s 2025 Annual Meeting of Stockholders
On March 28, 2025, Werner Cautreels notified Traws Pharma, Inc. (the Company”) of his decision to retire and resign from his role as Chief Executive Officer of the Company, effective as of the close of business on the day that the Company files its Annual Report on Form 10-K for its 2024 fiscal year
On March 24, 2025, Gerard Waldt notified the Board of Trustees (the “Board”) of T. Rowe Price OHA Select Private Credit Fund (the “Company”) of his resignation as the Company’s Chief Financial Officer
On March 24, 2025, Gerard Waldt notified the Board of Managers (the “Board”) of OHA Senior Private Lending Fund (U), LLC (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
Matthew Winkler resigned from the Board, effective immediately prior to the shareholders meeting to be held in 2025
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
On March 25, 2025, Isabelle F. Geday notified the board of directors (the “Board”) of Arteris, Inc. (the “Company”) of her decision to resign from the Board, effective as of March 27, 2025.
On March 24, 2025, Mr. Carl E. Vogel, a director elected by holders of the Class A Common Stock of Sphere Entertainment Co. (the “Company”), notified the Company of his intention not to stand for re-election when his term expires at the Company’s upcoming 2025 Annual Meeting of Stockholders anticipated to be held on June 4, 2025 (the “Annual Meeting”).
Pursuant to the Prigge Separation Agreement, effective as of March 31, 2025 (the "Transition Date"), Ms. Prigge will continue to serve at 3 ⁄ 4 full time as the Company’s Executive Vice President, Chief Service Delivery Officer during the period commencing on the Transition Date and ending on June 6, 2025 (such period, the "Transition Period").
On March 27, 2025, David L. Herzog, a director of MetLife, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to resign from the Board, effective May 1, 2025, and not to stand for re-election at the Company’s 2025 annual meeting of shareholders.
On March 26, 2025, EnerSys separated employment with Joern Tinnemeyer, EnerSys’ Senior Vice President and Chief Technology Officer.
L. Michelle Moore's appointment as a member of the Tennessee Valley Authority Board of Directors ended March 27, 2025, at the direction of the President of the United States.
On March 24, 2025, William W. Stead, M.D. notified HealthStream, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) as a Class I director at the Company’s annual meeting of stockholders and to retire from service on the Board effective concurrently with this annual meeting.
On March 27, 2025, Dr. Madaus notified the Board of his intention to resign from the Board and each committee of the Board on which he serves no later than the date of the Company's 2025 annual meeting of stockholders
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.